603233.SS
603233.SS
CNE100002RG2
DASHENLIN PHARMACEUTICAL GROUP
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 27.502.188.411 26.496.547.002
3.8%
Cost of Revenue 18.064.052.811 17.401.139.013
3.8%
Gross Profit 9.438.135.600 9.095.407.989
3.8%
7.342.943.516 7.483.283.243
1.9%
Operating Income 2.095.192.085 1.612.124.746
30.0%
Pretax Income 1.849.447.594 1.339.672.690
38.1%
Net Income Common Stockholders 1.235.246.215 914.754.951
35.0%
-- --
--
-- --
--
ende